NovaBay Pharmaceuticals is a clinical-stage biotechnology company engaged in developing two distinct categories of product offerings to address the large, unmet therapeutic needs of the worldwide anti-infective market. The company’s first-in-class Aganocide compounds are patented synthetic molecules that mimic white blood cells to fight against bacteria, viruses and fungi. NovaBay’s NeutroPhase product is being developed for advanced wound care. For more information, visit the company’s Web site at www.novabaypharma.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: